書籍詳細

P.52 掲載の参考文献

• 1) Acute Oral Toxicity Study of NSC-24 in Rats. Essex Testing Clinic. 1990, NJ, USA.

• 2) Andrassy RJ, DuBois T, Page CP, Patterson RS, Paredes A:Early postoperative nutritional enhancement utilizing enteral branched-chain amino acids by way of a needle catheter jejunostomy. Am J Surg 150(6):730-734, 1985.
  pubmed

• 3) Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G:Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol 97(4):1437-1444, 2004.
  pubmed

• 4) Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G:Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions. Jr Appl Physiol 95(2):491-496, 2003.

• 5) Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P:A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator(PGG-glucan) in high-risk surgical patients. Arch Surg 129(11):1204-1210, 1994.

• 6) Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA:Randomized phase I/II trial of a macrophage-specific immunomodulator(PGG-glucan) in high-risk surgical paticnts. Ann Surg 220(5):601-609, 1994.

• 7) Beck MA, Shi Q, Morris VG, Levander OA:Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1(5):433-436, 1995.

• 8) Beck MA, Levander OA, Handy J:Selenium deficiency and viral infection. J Nutr 133(5 Suppl 1):1463S-1467S, 2003.

• 9) Bistrian BR, Blackburn GL, Vitale J, Cochran D, Naylor J:Prevalence of malnutrition in general medical patients. JAMA 235(15):1567-1570, 1976.
  pubmed

• 10) Bogden JD, Bendich A, Kemp FW, Bruening KS, Shurnick JH, Denny T, Baker H, Louria DB:Daily micronutrient supplements enhance delayed-hypersensitivity skin test responses in older people. Am J Clin Nutr 60(3):437-447, 1994.
  pubmed

• 11) Bouic PJ, Etsebeth S, Liebenberg RW, Albrecht CF, Pegel K, Van Jaarsveld PP:beta-Sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation:implications for their use as an immunomodulatory vitamin combination. lnt J Immunopharzacol 18(12):693-700, 1996.

• 12) Brousseau M, Miller SC:Enhancement of natural killer cells and increased survival of aging mice fed daily Echinacea root extract from youth. Biogerontology 6(3):157-163, 2005.
  pubmed

• 13) Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S:Suppressive effect of active hexose correlated compound(AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr Regul 34(4):181-188, 2000.
  pubmed

• 14) CDC '98:Prescribing Guidelines. Pediatrics 101:163-184,1998.

• 15) Chandra RK:Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 340(8828):1124-1127, 1992.
  pubmed

• 16) Chandra RK:Graying of the immune system. Can nutrient supplements improve immunity in the elderly? JAMA 277(17):1398-1399, 1997.
  pubmed

• 17) Chandra RK:Influence of multinutrient supplement on immune responses and infection-related illness in 50-65 year old individuals. Nutr Res 22:5-11, 2002.
  pubmed

• 18) Czop JK, Austen KF:A beta-glucan inhibitable receptor on human monocytes:its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol 134(4):2588-2593, 1985.
  pubmed

• 19) Daly JM, Hearne B, Dunaj J, LePorte B, Vikram B, Strong E, Green M, Muggio F, Groshen S, DeCosse JJ:Nutritional rehabilitation in patients with advanced head and neck cancer receiving radiation therapy. Am J Surg 148(4):514-520, 1984.
  pubmed

• 20) de Felippe JJ, da Rocha e Silva JM, Maciel FM, Soares Ade M, Mendes NF:Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose(glucan). Surg Gynecol Obstet 177(4):383-388, 1993.

• 21) Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE:Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastro-intestinal Study Group. Arch Surg 134(9):977-983, 1999.
  pubmed

• 22) Di Luzio NR, Williams DL:The role of glucan in the prevention and modification of microparasitic diseases. In:Assessments of chemical regulation of immunity in veterinary medicine. Gainer JH, ed. NY:Scientific, Medical and Scholarly Pub., 1983.

• 23) ECDC Influenza Team:H5N1 virus resistant to oseltamivir isolated from Vietnamese patient. Euro Surveill 10(10):EO51020.2, 2005.

• 24) Edington J, Winter PD, Coles SJ, Gale CR, Martyn CN:Outcomes of undernutrition in patients in the community with cancer or cardiovascular disease. Proc Nutr Soc 58(3):655-661, 1999.
  pubmed

• 25) Fietkau R:Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy. Strahlenther Onkol 174(Suppl 3):47-51, 1998.
  pubmed

• 26) Gallagher-Allred CR, Voss AC, Finn SC, McCamish MA:Malnutrition and clinical outcomes:the case for medical nutrition therapy. J Am Diet Assoc 96(4):361-366, 369, 1996.
  pubmed

• 27) Goldman R:Characteristics of the beta-glucan receptor of murine macrophages. Exp Cel Res 174(2):481-490, 1988.

• 28) Hahn MG, Albersheim P:Host-Pathogen Interactions:XIV. Isolation and Partial Characterization of an Elicitor from Yeast Extract. Plant Physiol 62(1):107-111, 1978.
  pubmed

• 29) Jain AL:Influence of vitamins and trace-Clements on the incidence of respiratory infection in the elderly. Nutr Res 22:85-87, 2002.

• 30) Jung K, Ha Y, Ha SK, Han DU, Kim DW, Moon WK, Chae C:Antiviral effect of Saccharomyces cerevisiae beta-glucan to swine influenza virus by increased production of interferon-gamma and nitric oxide. J Vet Med Infect Dis Vet Public Health 51(2):72-76, 2004.

• 31) Kernodle DS, Gates H, Kaiser AB:Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopyranose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob Agents Chemother 42(3):545-549, 1998.

• 32) Lahnborg G, Hedstrom KG, Nord CE:The effect of glucan-a host resistance activator-and ampicillin on experimental intraabdominal sepsis. J Reticuloendothel Soc 32(5):347-353, 1982.
  pubmed

• 33) Leibovich SJ, Danon D:Promotion of wound repair in mice by application of glucan.J Reticuloendothel Soc 27(1):1-11, 1980.
  pubmed

• 34) Lindegardh N, Hien TT, Farrar J, Singhasivanon P, White NJ, Day NP:A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu. J Pharm Biomed Anal 42(4):430-433, 2006.
  pubmed

• 35) Mandeville R:Biophage Pharma Inc, personal communication.

• 36) Mansell PWA, Ichinose H, Reed RJ, Krementz ET, McNamee R, Di Luzio NR:Macrophage-mediated destruction of human malignant cells in vivo. J Nat Cancer Inst 54(3):571-580, 1975.

• 37) Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y:Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods:a prospective cohort study.J Hepatol 37(1):78-86, 2002.
  pubmed

• 38) Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M:Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs 9(4):343-350, 1998.
  pubmed

• 39) Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, Thompson C, Pedrosa MC, Diamond RD, Stollar BD:Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 277(17):1380-1386, 1997.
  pubmed

• 40) Naber TH, Schermer T, de Bree A, Nusteling K, Eggink L, Kruimel JW, Bakkeren J, van Heereveld H, Katan MB:Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 66(5):1232-1239, 1997.
  pubmed

• 41) Normile D:Infectious diseases. Genetic analyses suggest bird flu virus is evolving. Science 308(5726):1234-1235, 2005.
  pubmed

• 42) Nyquist AC, Gonzales R, Steiner JF, Sande MA:Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 279(11):875-877, 1998.
  pubmed

• 43) Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G:Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3 glucopyranose glucan in vivo. lnfect Immun 60(4):1642-1647, 1992.
  pubmed

• 44) Patchen ML, D'Alesandro MM, Brook I, Blakely WF, McVittie TJ:Glucan:mechanisms involved in its "radioprotective" effect. J Leukoc Biol 42(2):95-105, 1987.

• 45) Patchen ML, McVittie TJ:Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. lnt J Immunopharmacol 7(6):923-932, 1985.

• 46) Rasmussen LT, Konopski Z, Oian P, Seljelid R:Killing of Escherichia coli by mononuclear phagocytes and neutrophils stimulated in vitro with beta-1, 3-D-polyglucose derivatives. Microbiol Immunol 36(11):1173-1188, 1992.

• 47) Rasmussen LT, Seljelid R:Novel immunomodulators with pronounced in vitro effects caused by stimulation of cytokine release. J Cell Biochem 46(1):60-68,1991. Quote:"Beta-1,3-D-polyglucose derivatives protect mice against otherwise lethal bacterial infections."

• 48) Rasmussen LT, Seljelid R:Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1, 3-D-polyglucose derivatives. I. Cells. Scand J lmmunol 32(4):321-331, 1990.
  pubmed

• 49) Rasmussen LT, Fandrem J, Seljelid R:Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1, 3-D-polyglucose derivatives. II. Interleukin 1, tumor necrosis factor, prostaglandin E2, and leukotriene B4. Scand J lmmunol 32(4):333-340, 1990.
  pubmed

• 50) Rasmussen LT, Seljelid R:The modulatory effect of lipoproteins on the release of interleukin 1 by human peritoneal macrophages stimulated with beta-1,3-D-polyglucose derivatives. Scand J Immunol 29(4):477-484, 1989.
  pubmed

• 51) Rasmussen LT, Lipsky PE, Seljelid R:Production of prostaglandin E2 and interleukin 1 by mouse peritoneal macrophages stimulated with beta-1, 3-D-glucan derivatized plastic beads. Scand J Immunol 26(6):731-736, 1987.
  pubmed

• 52) Rasmussen LT, Fandrem J, Seljelid R:Dynamics of Blood Components and Peritoneal Fluid During Treatment of Murine E. Coli Sepsis with beta-1, 3-D-polyglucose Derivatives. Scand J Immunol 63:73-80, 1985.

• 53) Rayman, MP:Dietary selenium:time to act. BMJ 314(7078):387-388, 1997.
  pubmed

• 54) Robertsen B, Engstad RE, Jorgensen JB:Beta-glucans as Immunostimulants in fish. Immune Responses 1994, V.1 Fair Haven, NJ, USA.

• 55) Song YL, Hsieh YT:Immunostimulation of tiger shrimp(Penaeusmonodon) hemocytes for generation of microbicidal substances:analysis of reactive oxygen species. Dev Comp Immunol 18(3):201-209, 1994. Elsevier Science.

• 56) Suzuki, Hashimoto K, Ohno K, Tanaka H, Yadomae T:Immunomodulation by orally administered beta-glucan in mice. Int J Immunopharmacol II(7):761-769, 1989.

• 57) Tzianabos AO, Cisneros RL:Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria. Ann NY Acad Sci 797:285-287, 1996.
  pubmed

• 58) Vetvicka V, Terayama K, Mandeville R, Brousseau P, Kournikakis B, Ostroff G:Pilot Study:Orally-Administered Yeast Beta1, 3-glucan Prophylactically Protects Against Anthrax Infection and Cancer in Mice. Jr Am Nutraceutical Assocn 5:1-5, 2002.

• 59) Wakame K:Protective effects of active hexose correlated compound(AHCC) on the onset of diabetes in the rat. Biomed Res:145-152, 1999.

• 60) Wakshull E, Brunke-Reese D, Lindermuth J, Fisette L, Nathans RS, Crowley JJ, Tufts JC, Zimmerman J, Mackin W, Adams DS:PGG-glucan, a soluble beta-(1.3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN:evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 41(2):89-107, 1999.
  pubmed

• 61) Washburn WK, Otsu I, Gottschalk R, Monaco AP:PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection. J Surg Res 62(2):179-183, 1996.
  pubmed

• 62) Williams DL, Sherwood ER, Browder IW, McNamee RB, Jones EL, Di Luzio NR:Pre-clinical safety evaluation of soluble glucan. Int J Immunopacol 10(4):405-414, 1988.

• 63) Williams DL, Di Luzio NR:Modification of Experimental Viral hepatitis by Glucan Induced Macrophage Activation. In:Reticuloendothelial System and Pathogenesis of Liver Disease, Liehr and Grun, eds. Elsevier/North Holland Biomedical Press, pp.363-368, 1983.

• 64) Williams DL, Di Luzio NR:Glucan-induced modification of murine viral hepatitis. Science 208(4439):67-69, 1980.
  pubmed

• 65) Williams DL, Cook JA, Hoffmann EO, Di Luzio NR:Protective effect of glucan in experimentally induced candidiasis.Reticuloendothel Soc 23(6):479-490, 1978.
  pubmed

• 66) Williams DL, Di Luzio NR:Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosup-pressed mice. Adv Exp Med Biol 121(A):291-306, 1979.

• 67) Yagita A, Maruyama S, Fujituka M, Ohshima K:Novel immunotherapy using a human natural(Hn) IL-12 inducer. Jpn J Cancer Res 89:(abstr) 2422, 1998.

• 68) Yagita A, Maruyama S, Wakasugi S, Sukegawa Y:H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo 16(1):49-54, 2002.
  pubmed

• 69) Yen HL, Monto AS, Webster RG, Govorkova EA:Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogeniv A/Vietnam/1203/04 influenza virus in mice. J lnfect Dis 192(4):665-672, 2005.
  pubmed